Leading the way with robotic IV automation systems
Advanced IV compounding robotic technology, novel data services, and expertly trained pharmacy technician staff to help you create a safer, more accurate, and more cost-effective IV pharmacy.
Health systems are continuously being challenged to ensure IV preparations are prepared safely and accurately while complying with increasingly complex regulations.
Omnicell's robotic IV automation system empowers pharmacists and technicians with tools to improve dose accuracy and make IV pharmacy compounding safer while reducing costs and enabling compliance.
IV sterile compounding automation expands capabilities
Omnicell is the global leader in robotic IV automation systems. The groundbreaking design of our new IVX Station compounding robot addresses previous industry concerns with throughput and reliability. Our deep commitment to improving sterile IV compounding is also delivered through our IVX Workflow solution, novel data services, application support, and automation expertise.
Instead of outsourcing to 503B compounding pharmacies, turn to Omnicell for safer, more efficient ways to manage IV therapy medications in-house.
The technology, tools, and technicians are provided to enable success from day one.
Reduce costs through decreased 503B drug spend and waste.
Improve quality and accuracy of IV medications through our semi-automated workflow system and fully automated IV compounding.
Decrease your reliance on 503B vendors and help mitigate drug shortages, which impact patient care.
Stay on top of performance and compliance auditing through automated documentation.
Optimize sterile compounding operations with robust analytics and benchmarking.
Related Products
Includes the groundbreaking IVX Station compounding robot along with tools and clinical expertise needed to operate and optimize the technology.
Learn more
Omnicell’s enterprise software, designed to integrate and standardize your sterile compounding operations to enhance patient safety, improve efficiency, and enable compliance.
Learn more
"IV robotic insourcing allows us to protect our supply chain, to continue providing ready-to-administer products and to avoid switching to other products that could be less safe."
Kevin Hansen, PharmD, MS, MCPS, Assistant Director of Pharmacy, Moses H. Cone Memorial Hospital
503B compounding pharmacy alternative
Omnicell offers a comprehensive service model that provides the IVX Station robot technology, the tools, and the clinical support to run your IV robotics insourcing program, allowing you to focus on patient care.
Omnicell’s IV Compounding Service includes the pharmacy technician to manage the fully automated IV compounding technology, along with tools and clinical optimization support — all for a simple monthly fee that’s a fraction of your 503B outsourcing spend. Adopting and realizing value from robotic IV automation systems has never been easier.
This outcome-based solution makes IV robotics affordable, easy to implement, and assured to drive value.
Omnicell provides the technology, tools, pharmacy technicians, and clinical optimization support to run your IV robotics insourcing program.
Omnicell contractually commits to hitting your IV sterile compounding production quotas.
Leverage Omnicell’s clinical pharmacists to evaluate your ongoing compounding demand to help drive optimization and return on investment.
Mitigate risk by avoiding up-front capital investment. Our simple monthly fee for service model enables you to capture early wins and smoothly evolve with the technology.
Partner with Omnicell to drive improved operational expertise by leveraging data from millions of IV preps worldwide through the REINVENT program.
Clinical go-live, on-site support, pharmacy consultants, regional help desks, field engineering, lab support, and regulatory consultants are all accessible within the program.
Why choose pharmacy technology as a service?
Watch this video for an overview of Omnicell’s full-service, subscription-based model that enables a clear, quick path to improved outcomes with no capital investment.
Leverage clinical services and benchmarking data to maximize ROI
A successful robotic sterile compounding operation is about more than just the technology. Inventory management, extended beyond-use dating, and benchmarking are all key to ensuring your IV pharmacy operation is optimized and delivering continuous value for your hospital or health system.
Omnicell has developed pharmacy service programs and partnerships that help our customers solve IV compounding challenges.
A successful robotic sterile compounding operation is about more than just the technology. Inventory management, extended beyond-use dating, and benchmarking are all key to ensuring your IV pharmacy operation is optimized and delivering continuous value for your hospital or health system.
Omnicell has developed pharmacy service programs and partnerships that help our customers solve IV compounding challenges.
Formulary Tool Kit helps you quickly adopt, fully leverage, and maximize return of your investment in IV robotic technology by providing immediately available, low cost access to cGMP stability data and specific gravity data for most common compounded sterile preparations (CSPs). We do this through a partnership with Analytical Research Laboratories (ARL), an FDA-registered lab.
Learn more
Case Study
TidalHealth Realizes Savings, Efficiency Gains with IV Compounding Service
Learn how TidalHealth pharmacy leaders accelerated realization of their CSP program goals after switching to a new as-a-service model for IV compounding automation.
White Paper
Sterile IV Compounding Automation: Robotic Technology Reimagined
Despite the clear safety, accuracy, compliance, cost, and supply chain benefits of IV compounding robots, there’s been limited adoption. Find out why – and how Omnicell is addressing it.
More Resources
Explore a variety of informative materials to inspire your journey to an autonomous pharmacy
Webinar
Reducing Drug Spend with IV Robotic Services
Learn how Moses H. Cone Memorial Hospital is leveraging IV automation combined with services to reduce the need for outsourcing and reduce drug waste in the OR.
